Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PDCD7 mRNA | affects expression | 21346803
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of PDCD7 mRNA | increases expression | 19371625
|
D015025 |
Zearalenone |
Zearalenone results in increased expression of PDCD7 mRNA | increases expression | 19371625
|
D019833 |
Genistein |
Genistein results in increased expression of PDCD7 mRNA | increases expression | 19371625
|
C016340 |
o,p'-DDT |
o,p'-DDT results in increased expression of PDCD7 mRNA | increases expression | 19371625
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PDCD7 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C059514 |
resveratrol |
resveratrol results in increased expression of PDCD7 mRNA | increases expression | 19371625
|
D014501 |
Uranium |
Uranium affects the expression of PDCD7 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of PDCD7 mRNA | affects expression | 15672453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.06 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.52 | 11473722 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.42 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.76 | 16434500 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.60 | 16162502 16183991 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.62 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.38 | 16873680 17967414 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.35 | 19483382 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.07 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.57 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.03 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.03 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.03 | 17534123 17651959 16393696 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.84 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.84 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.84 | 19321006 16227395 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.27 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.88 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.76 | 16227395 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.97 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.97 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.90 | 6135515 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.39 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
4.04 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
4.04 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.87 | 16507316 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.28 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.94 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.52 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.14 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.02 | 18551238 21346803 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.59 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
7.59 | 8985016 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.26 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.87 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
3.49 | 11473722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.11 | 17923197 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.97 | 19236843 20131406 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.38 | 16598420 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.25 | 19176532 16221962 19772884 18467677 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.46 | 16876885 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.21 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.25 | 16873680 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.50 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.91 | 17600658 |
MESH:D007249 |
Inflammation |
|
resveratrol |
2.94 | 16366677 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.86 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.74 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.74 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.15 | 16705839 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.11 | 18980019 17468513 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.70 | 16087638 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
2.49 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.49 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.86 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.86 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.86 | 19073162 19321006 19812893 20405173 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.66 | 2876786 2876784 6135515 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.52 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
4.04 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.53 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.71 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.71 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.39 | 17992120 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.58 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.61 | 17935668 17049120 16267019 17164350 14749477 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.16 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.94 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.94 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.94 | 16456233 16317513 17125593 16525036 17015251 17188708 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
4.17 | 17125593 17015251 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.92 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.92 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.04 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.15 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.03 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.26 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.69 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
10.69 | 16427766 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.62 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.62 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.37 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
10.90 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
10.90 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.27 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.65 | 19005980 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.84 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
10.84 | 16679765 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.41 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.64 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.64 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.64 | 17804756 17636462 16731767 17675339 17718901 15767336 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.07 | 10548101 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.90 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.87 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.87 | 17520802 16314181 16317513 17058453 15827377 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.67 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
3.11 | 15837718 8985016 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.67 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.27 | 16684133 16045194 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.41 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.35 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.29 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.33 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.37 | 17044934 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.56 | 17488730 |